SCHEMBL20390886

SCHEMBL20390886

Cc1ncc(-c2cccc(N)n2)[nH]1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 1/20 0.44
▸ ASIC3 Q9UHC3 1/20 0.43
▸ NOS3 P29474 2/20 0.42
▸ NOS2 P35228 2/20 0.42
▸ BRS3 P32247 1/20 0.36
▸ IDH1 O75874 4/20 0.36
▸ PDPK1 O15530 1/20 0.36
▸ JAK2 O60674 1/20 0.35
▸ IRAK4 Q9NWZ3 1/20 0.35
▸ HRH1 P35367 1/20 0.34
▸ HRH4 Q9H3N8 1/20 0.34
▸ NOS1 P29475 1/20 0.33
▸ BAZ2B Q9UIF8 1/20 0.33
▸ MASP2 O00187 1/20 0.33
▸ CBFB Q13951 1/20 0.33
▸ CCR1 P32246 1/20 0.32
▸ CCR8 P51685 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19087099 0.73 CYP2A6 (0.51) CYP2A6CBFBCCR1CCR8
SCHEMBL30855633 0.72 CCR1 (0.50) CYP2A6NOS3NOS2JAK2MASP2
SCHEMBL24427822 0.72 NOS3 (0.42) CYP2A6NOS3NOS2HRH1HRH4
SCHEMBL23956584 0.72 CYP2A6 (0.50) CYP2A6NOS3NOS2HRH1HRH4
SCHEMBL24427844 0.71 CYP2A6 (0.42) CYP2A6JAK2HRH1HRH4BAZ2B
SCHEMBL20834890 0.70 NPC1 (0.50) —
SCHEMBL20834685 0.70 RAB9A (0.50) —
SCHEMBL24427364 0.70 CYP2A6 (0.36) CYP2A6NOS3NOS2JAK2HRH1
SCHEMBL24427823 0.70 PIM2 (0.39) CYP2A6NOS3NOS2HRH1HRH4
SCHEMBL1073895 0.70 ASIC3 (0.68) ASIC3NOS3NOS2IDH1PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3998263-A1 TRICYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Jemincare Pharmaceuticals Co., Ltd. (CN) 2022-05-18 — — EP disclosed
EP-2203435-B1 6, 11-BRIDGED BIARYL MACROLIDES ENANTA PHARM INC (US) 2018-07-18 — — EP disclosed
Send feedback